An evaluation of a brief psychological treatment for major depression in primary care

An evaluation of a brief psychological treatment for major depression in primary care

Bibliographic Details
Main Author:	Mynors-Wallis, Laurence Mark
Published:	University of Oxford 1994
Subjects:	610 Antidepressants
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.239346

Similar Items

Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisis
by: Sicras-Mainar A, et al.
Published: (2015-12-01)

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care
by: José Salazar-Fraile, et al.
Published: (2018-09-01)

DEPRESSION IN PRIMARY CARE. PART 2: MANAGEMENT
by: XV Pereira, et al.
Published: (2007-01-01)

The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder
by: Jay Fawver, et al.
Published: (2020-07-01)

A Study of Antidepressant Prescription in Major Depressive Disorders in the Out-Patient Psychiatric Department of Siriraj Hospital
by: Somporn Wipisamakul, et al.
Published: (2005-08-01)

Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
by: Cornelis F. Vos, et al.
Published: (2021-10-01)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-04-01)

Neuroendocrine Assessment of Dopaminergic Function during Antidepressant Treatment in Major Depressed Patients
by: Fabrice Duval, et al.
Published: (2021-03-01)

Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients
by: Orestes Vicente Forlenza, et al.
Published: (2000-07-01)

Major depressive disorder in children and adolescents
by: Mullen, S.
Published: (2018)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
by: Harada E, et al.
Published: (2016-01-01)

Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines
by: Martin Plöderl, et al.
Published: (2019-09-01)

Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care
by: Sicras-Mainar Antoni, et al.
Published: (2012-08-01)

Synthesis and anti-depressant evaluation of novel pyrazolone derivatives
by: Vijay Kumar Merugumolu, et al.
Published: (2016-05-01)

Treatment-Resistant Major Depression:Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
by: Charles eZorumski, et al.
Published: (2015-12-01)

How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist
by: Bernardo Dell’Osso, et al.
Published: (2020-10-01)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-07-01)

Longitudinal monitoring of the course of depressive disorders: Careful monitoring of the course of depressive episode
by: Kostić Milutin, et al.
Published: (2020-01-01)

The Impact of Efficacious Treatments for Major Depressive Disorder on Remission Rates of Specific Symptoms: A Re-Analysis of the Treatment of Depression Collaborative Research Program
by: Stewart, JEREMY
Published: (2009)

Severe refractory intraoperative hypotension in a patient with major depression under long-term antidepressant treatment: A case of left nephrectomy surgery
by: Hsiao-Cheng Chang, et al.
Published: (2018-01-01)

Enhanced care by community health workers in improving treatment adherence to antidepressant medication in rural women with major depression
by: Johnson Pradeep, et al.
Published: (2014-01-01)

Diagnosis, phenomenology and treatment of poststroke depression
by: Starkstein Sergio E, et al.
Published: (2002-01-01)

PBMC telomerase activity correlates with hippocampal volume in major depression
by: Owen M. Wolkowitz, et al.
Published: (2012-09-01)

Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
by: Garcia-Toro Mauro, et al.
Published: (2012-09-01)

Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial
by: Mohammad Reza Mohammadi, et al.
Published: (2006-03-01)

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial
by: Zuilhof Z, et al.
Published: (2018-11-01)

Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial
by: Mohammad Reza Mohammadi, et al.
Published: (2006-04-01)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
by: Andrea Fontana, et al.
Published: (2020-08-01)

Heart Rate Variability for the Prediction of Treatment Response in Major Depressive Disorder
by: Kwan Woo Choi, et al.
Published: (2020-06-01)

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
by: Novick D, et al.
Published: (2016-02-01)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Caroline Kamp Jørgensen, et al.
Published: (2021-08-01)

Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT
by: Larisa Duffy, et al.
Published: (2019-12-01)

Pathogenesis, clinical features, and treatments of depression in Parkinson's disease
by: I. V. Milyukhina
Published: (2019-06-01)

THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSIVE DISORDERS ASSOCIATED WITH EPILEPSY
by: L. V. Lipatova, et al.
Published: (2016-12-01)

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
by: Zhang L, et al.
Published: (2016-04-01)

S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review
by: Alessandro Cuomo, et al.
Published: (2020-09-01)

Placebo Effect in the Treatment of Depression and Anxiety
by: Irving Kirsch
Published: (2019-06-01)

Oligodendrocyte Pathology in Major Depressive Disorder Reveals New Targets for the Development of a Novel Class of Antidepressant Drugs
by: Ordway, Gregory A.
Published: (2017)

Unifying treatments for Depression: An application of the Free Energy Principle
by: Adam Mourad Chekroud, et al.
Published: (2015-02-01)

Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder
by: Ian A. Cook, et al.
Published: (2019-09-01)